Abstract
Fever of unknown origin is a clinical condition when the elevated body temperature is 38.3 °C or higher in the last 3 weeks and remaining undiagnosed after propriate investigation. The literature is very limited in pediatric patients compared to adults. Inflammation, infection, malignancy and others are in the differential diagnosis. The problem is the known problem presenting in an unknown clinical scenario. F-18 fluorodeoxyglucose (FDG) positron emission tomography/computerized tomography (PET/CT) is sensitive imaging method in the evaluation of fever of unknown origin. In this review the role of F-18 FDG PET/CT is going to be discussed in pediatric population.
Keywords: Fever of unknown origin, pediatrics, FDG PET/CT
References
Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore). 1961;40:1-30.
Durack DT, Street AC. Fever of unknown origin—reexamined and redefined. Curr Clin Top Infect Dis. 1991;11:35-51.
de Kleijn EM, van Lier HJ, van der Meer JW. Fever of unknown origin (FUO). II. Diagnostic procedures in a prospective multicenter study of 167 patients. The Netherlands FUO Study Group. Medicine (Baltimore). 1997;76:401-414.
Bleeker-Rovers CP, Vos FJ, de Kleijn EM, et al. A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore). 2007;86:26-38.
Antoon JW, Potisek NM, Lohr JA. Pediatric fever of unknown origin. Pediatr Rev. 2015;36:380-390.
Chusid MJ. Fever of Unknown Origin in Childhood. Pediatr Clin North Am. 2017;64:205-230.
Tolan RW Jr. Fever of unknown origin: a diagnostic approach to this vexing problem. Clin Pediatr. 2010;49:207-213.
Wright WF, Betz JF, Auwaerter PG. prospective studies comparing structured vs nonstructured diagnostic protocol evaluations among patients with fever of unknown origin: a systematic review and meta-analysis. JAMA Netw Open. 2022;5:e2215000.
Krupa R, Zielonka TM, Hadzik-Blaszczyk M, Wardyn KA, Zycinska K. Lung lesions during fever of unknown origin. Adv Exp Med Biol. 2017;1022:35-43.
Tavakoli AA, Reichert M, Blank T, et al. Findings in whole body MRI and conventional imaging in patients with fever of unknown origin-a retrospective study. BMC Med Imaging. 2020;20:94.
Takeuchi M, Dahabreh IJ, Nihashi T, Iwata M, Varghese GM, Terasawa T. Nuclear imaging for classic fever of unknown origin: meta-analysis. J Nucl Med. 2016;57:1913-1919.
Ahn SS, Hwang SH, Jung SM, et al. Evaluation of spleen glucose metabolism using (18)F-FDG PET/ CT in patients with febrile autoimmune disease. J Nucl Med. 2017;58:507-513.
Kong MC, Nadel HR. 18F-FDG PET/CT with diffusely high FDG uptake throughout subcutaneous adipose tissues. Clin Nucl Med. 2018;43:762-763.
Liu B, Lee NJ, Otero HJ, Servaes S, Zhuang H. Rosai-Dorfman disease mimics lymphoma on FDG PET/CT in a pediatric patient. Clin Nucl Med. 2014;39:206-208.
Thomas DL, Syrbu S, Graham MM. Epstein-Barr virus mimicking lymphoma on FDG-PET/CT. Clin Nucl Med. 2009;34:891-893.
Ferda J, Ferdova E, Zahlava J, Matejovic M, Kreuzberg B. Fever of unknown origin: a value of (18)F-FDG-PET/CT with integrated full diagnostic isotropic CT imaging. Eur J Radiol. 2010;73:518-525.
Simons KS, Pickkers P, Bleeker-Rovers CP, Oyen WJ, van der Hoeven JG. F-18 fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection. Intensive Care Med. 2010;36:504-511.
Sturm E, Rings EHHM, Scholvinick E, Gouw AS, Porte RJ, Pruim J. Fluorodeoxyglucose positron emission tomography contributes to management of pediatric liver transplantation candidates with fever of unknown origin. Liver Transpl. 2006;12:1698-1704.
Jasper N, Dabritz J, Frosch M, Loeffler M, Weckesser M, Foell D. Diagnostic value of [18-F]-FDG PET/CT in children with unknown origin or unexplained signs of inflammation. Eur J Nucl Med Mol Imaging. 2010;37:136-145.
Yang J, Zhuang H. The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients. Hell J Nucl Med. 2015;18:136-139.
Pijl JP, Kwee TC, Legger GE, et al. Role of FDGPET/CT in children with fever of unknown origin. Eur J Nucl Med Mol Imaging. 2020;47:1596-1604.
Nygaard U, Laerke Vinge L, Vissing L, et al. Unexplained fever in children—benefits and challenges of FDG-PET/CT. Acta Paediatrica. 2022;111:2203-2209.
Li Q, Tian R, Wang H, et al. Quantifying the contribution of 18F-FDG PET to the diagnostic assessment of pediatric patients with fever of unknown origin: a systematic review and metaanalysis. Pediatr Radiol. 2022;52:1500-1511.
Gomez L, Chaumet-Riffaud P, Noel N, et al. Eur J Nucl Med Mol Imaging 2018, 45: 575-581
Pereira AM, Husmann L, Sah BR, Battegay E, Franzen D. Determinants of diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin. Nucl Med Commun. 2016;37:57-65.
Liu B, Ma R, Shum E, et al. FDG-PET/ CT for investigation of pyrexia of unknown origin: a cost of illness analysis. Eur J Nucl Med Mol Imaging. 2024;51:1287-1296.
